{"name":"KU Leuven","slug":"ku-leuven","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"sterile talc pleurodesis","genericName":"sterile talc pleurodesis","slug":"sterile-talc-pleurodesis","indication":"Other","status":"phase_2"},{"name":"Suspension Fasted State","genericName":"Suspension Fasted State","slug":"suspension-fasted-state","indication":"Other","status":"phase_1"},{"name":"Syntocinon (Oxytocin)","genericName":"Syntocinon (Oxytocin)","slug":"syntocinon-oxytocin","indication":"Induction or augmentation of labor","status":"marketed"},{"name":"drugs linked with QT-prolongation","genericName":"drugs linked with QT-prolongation","slug":"drugs-linked-with-qt-prolongation","indication":"Other","status":"phase_2"},{"name":"Suspension Fed State","genericName":"Suspension Fed State","slug":"suspension-fed-state","indication":"Other","status":"phase_1"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Mepolizumab Injection [Nucala]","genericName":"Mepolizumab Injection [Nucala]","slug":"mepolizumab-injection-nucala","indication":"Severe eosinophilic asthma","status":"marketed"},{"name":"Tiotropium + formoterol/beclometasone","genericName":"Tiotropium + formoterol/beclometasone","slug":"tiotropium-formoterol-beclometasone","indication":"Chronic obstructive pulmonary disease (COPD) maintenance treatment","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"D-cure","genericName":"D-cure","slug":"d-cure","indication":"Colorectal cancer","status":"marketed"}]}],"pipeline":[{"name":"sterile talc pleurodesis","genericName":"sterile talc pleurodesis","slug":"sterile-talc-pleurodesis","phase":"phase_2","mechanism":"Induces pleural inflammation and fibrosis to create adhesion between visceral and parietal pleura, obliterating the pleural space.","indications":[],"catalyst":""},{"name":"D-cure","genericName":"D-cure","slug":"d-cure","phase":"marketed","mechanism":"D-cure is a therapeutic vaccine designed to stimulate the immune system to recognize and eliminate cancer cells expressing specific tumor-associated antigens.","indications":["Colorectal cancer","Other solid tumors (under investigation)"],"catalyst":""},{"name":"Suspension Fasted State","genericName":"Suspension Fasted State","slug":"suspension-fasted-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Syntocinon (Oxytocin)","genericName":"Syntocinon (Oxytocin)","slug":"syntocinon-oxytocin","phase":"marketed","mechanism":"Oxytocin is a neurohypophyseal hormone that binds to oxytocin receptors to stimulate uterine contractions and milk letdown.","indications":["Induction or augmentation of labor","Prevention and treatment of postpartum hemorrhage","Promotion of milk letdown during lactation"],"catalyst":""},{"name":"drugs linked with QT-prolongation","genericName":"drugs linked with QT-prolongation","slug":"drugs-linked-with-qt-prolongation","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mepolizumab Injection [Nucala]","genericName":"Mepolizumab Injection [Nucala]","slug":"mepolizumab-injection-nucala","phase":"marketed","mechanism":"Mepolizumab is a monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), reducing eosinophil production and activation in the blood and tissues.","indications":["Severe eosinophilic asthma","Eosinophilic granulomatosis with polyangiitis (EGPA)","Chronic rhinosinusitis with nasal polyps (eosinophilic phenotype)"],"catalyst":""},{"name":"Suspension Fed State","genericName":"Suspension Fed State","slug":"suspension-fed-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tiotropium + formoterol/beclometasone","genericName":"Tiotropium + formoterol/beclometasone","slug":"tiotropium-formoterol-beclometasone","phase":"marketed","mechanism":"This combination drug provides long-acting bronchodilation via tiotropium (anticholinergic) and formoterol (beta-2 agonist), plus anti-inflammatory action via beclometasone (inhaled corticosteroid) for maintenance treatment of chronic obstructive pulmonary disease and asthma.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance treatment","Asthma maintenance treatment"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPWl9pMWFTczQyU1AtUkFEdV9NZlJPS3pvSk41Yk5ZZEV1Mm0tQk5BcHk5eXM3bVJMbHRMUGNET292eVVjSC1pcm9XLXN4Zy1TNjFqOVpYbFprcVBDSkJvWFI1SGZwa3gyYU51NDh4SDkzTVA1VWZWZzZVcUQyQmppZ3NaZlVKZ25CMExYeDEwY2J2eEg3b1g0alF1UzB0RWd6Z1BzWkdvYXgyLVpuTk9pdlhMVUZhNXJ1STRYejNwdUJjN2pxamlxUnUtd09Cc2M2TmlYdi1vejdBZWQtTERqZEU5SlFjMWtQa0Fj?oc=5","date":"2026-02-17","type":"pipeline","source":"BioPharma APAC","summary":"Beactica Therapeutics AB Secures EUR 2.5 Million EIC Grant To Advance Precision Immune Therapy For Glioblastoma - BioPharma APAC","headline":"Beactica Therapeutics AB Secures EUR 2.5 Million EIC Grant To Advance Precision Immune Therapy For Glioblastoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPQm1kZHR6ZTlmLTdvWHJISWJIWmMwWk8zbzdSTUE4eHp4eTdRMlRoSHphWEcyVFhVbGFuWGFCTUJPQlZsWjhBSXhJTDZpUXdscG5nOUxEY2pFU1pxdXVIRVJ6ZUljYmpfVU9CNlRZWkNPSDVEX25fSUhza2tWQVFpeC1sbFBuX0JIbW9JNXkwa09nNm5YX3ZQOFMwYkFJVVppV0o4?oc=5","date":"2025-12-18","type":"pipeline","source":"UZ Leuven","summary":"Breast cancer patients too often receive unnecessary new cancer drugs - UZ Leuven","headline":"Breast cancer patients too often receive unnecessary new cancer drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQbW5hSjdCMGcyUEZNc21LS1RscHZkQ0tNcF9GWHR1QXZET0t6dzRZV0J4MHZsdnZZQndkVWFYSXZJT2pCOGtQS3FkSlYyXy1WMGlFZ01UZ3Z2Znpha1hTNFpRQnNFRGVULVVOQ0RYR2RJQTR6ak10dE1CVmQ2T0FuSU5RUGUtNEZNeUxmZnVMbTVabW56c2NHYXRYeXJFSUktVXp5WEVhVkNnY3QteXNBUkIyaEtrYUg3SDN0YnRHWlM?oc=5","date":"2025-05-15","type":"pipeline","source":"promarket.org","summary":"Do Private Equity and Other Investors Harm Competition in the Pharmaceutical Industry? - promarket.org","headline":"Do Private Equity and Other Investors Harm Competition in the Pharmaceutical Industry?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPc2Z0TmZEbjUweVgtRldRbTA3S190cWIwZnZrRC1VRlRqTFNsM1V5a05kRWhwZHlfX0pnOWQwenI4RDlZMDN2d1Myc1A2R0JVUGVSNGRZb1pLamJLU2ZSeHd2eEdfajQ3bXk1ZVpDS3cwMHhrdFVkM25zbXk0azNrOHJpYUJXMTVpVDlyZFNRVHRmcDE0LXpoZmR0VnBWYlRCdkR4cUFlYlQ5Y2RtekxycmR5T2I?oc=5","date":"2025-05-13","type":"deal","source":"Contract Pharma","summary":"eXmoor Pharma, KU Leuven Partner to Support New Cell & Gene Therapy Hub - Contract Pharma","headline":"eXmoor Pharma, KU Leuven Partner to Support New Cell & Gene Therapy Hub","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxObHVkT1hWQW12Sy1FYzRLVlVTOFJBLWdaYVJncVJyTGFxeVoxM05QaGpaZDNzUlRrbVJ6TFREZU05S3Zwc205OElTZkxyZ0E2aUs5OUxCbmFRMnlXNDRTcGpCVHppcGx5ZThWbmo3T0V2VmlaUzlZbkJjRkZkQ280VmRiR3pMM3JnT1Y4V1FjOXVmY3p1TnJHeHl3?oc=5","date":"2025-04-07","type":"pipeline","source":"PharmaTimes","summary":"Endlyz Therapeutics emerges with pipeline for Parkinson’s disease - PharmaTimes","headline":"Endlyz Therapeutics emerges with pipeline for Parkinson’s disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9xVlR2UDhRelJJV2l5WlJJaVJmSmpBd1l3LUNZWkhEeHhhU1N3RnBzTlRzSFpKSzExZFZKdUZ1QW14VkxmMXprclZISjlwOWZSamZF?oc=5","date":"2025-03-24","type":"pipeline","source":"FirstWord Pharma","summary":"Augustine pulls in €78M in hopes of successfully targeting HDAC6 - FirstWord Pharma","headline":"Augustine pulls in €78M in hopes of successfully targeting HDAC6","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOaVZlb2l4Vl9xbGxDZ1NrU2ZaWnRoOERBMk9ldFZUUW9DbS1RbEhKM193U18tY2JxSXRJdHNsZFZib3JYUEVLZHpkTmxRQlJnOE9sMUNkUUNaSzNNWVRJSjBYOGRLeUlfWmdSdl8xMENqQW5tLVdQbnh0M0NvUHctRnR3SE1ZVlRDdFVUVzhQY0hwXzZIWW1XaTlrYUhrdUxoNHJsa2VuUQ?oc=5","date":"2024-11-20","type":"pipeline","source":"UCB","summary":"UCB Belgium: A global hub of healthcare innovation - UCB","headline":"UCB Belgium: A global hub of healthcare innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZ1BzRjNKbnc2STQ4TTNVdWstU0dsNm9xZDRTWWVKLWZpWEQ1ZURneVpuUkZVZzRMZ2xVMWM3OVhPRHBXYThCdnlJbmdrWHozbXZRcVRaQ2psYVMxSnB6UjYzcWdDOTdFTENwSFkwT3N2Z2tkcnIyNlVKRS0tMnM2X0VoSEJaV2N5ZjhzdllZV2ktVHpzWVc5a05zUFlzVXpWb0Nhc3VfV0w4TlMxLW5McXBSZGQyT0FpZUtj?oc=5","date":"2024-09-18","type":"pipeline","source":"UCB","summary":"Healthcare Innovation: UCB and KU Leuven’s Collaborative Approach - UCB","headline":"Healthcare Innovation: UCB and KU Leuven’s Collaborative Approach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBkZFpwZThGRmtvRnRqQzk2NkJwZUJ0MWZUX2h0OWg1eGRBOWN4UW5HQ3JyeUNHcG9WbW1PSUo0Z2RVajZtd2g2RjN5RXNFSGViT2tWMzJ5VlRxUFFmOWxncUhiYnZWSkQxVTJ2VXJPaTFmTWdROVY4a3dn?oc=5","date":"2024-07-24","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Top 10 U.S. Biopharma Clusters 2024 - Genetic Engineering and Biotechnology News","headline":"Top 10 U.S. Biopharma Clusters 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPc3FncTVWcGVnbDNOVkFCcHBNTGFwNDZ0ejFnX25mYkR1RVBsb0VDZ2FqZHhtTmJsaUxuTWlvMVJDOEhKbUROb2xTY3dET0lNYkpLY0h0ZHVCeDJlYWFfc0VUMUdXSjRYR0hKZXNhVDI0WGQtdU1FNUZ2YTVWNFpGU0xBRTFvb1Q2NFMxY2N4OUJUbHR4ejZiX2lYZnI?oc=5","date":"2024-06-24","type":"pipeline","source":"Frontiers","summary":"Sterilization of micronized indomethacin - Frontiers","headline":"Sterilization of micronized indomethacin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOZXBsc1d6TEZWQmVzU3c1b0ttTGxadHIwM0pZSkwtV1QyNVlxcEtuMlBLM2otUnFKWkNDdHVSZHpsMUhFVF9GVV9ZcVZNdWRUZ0RsZVgwZGhkM1kyN2VxaDJfaW5Va21wbndtbTJVUml3MlBwT1NKOVN3azF3QWJqVUdqVXYwQkU4d0hLb1AzUkJZMDdQUVlWWGtrWWxYSDR3d0JkSWtZZ3lSRldWRERHaGQwbUg2dy1FRTRJaENhVVJzM0FtaFJFVA?oc=5","date":"2023-10-18","type":"pipeline","source":"KU Leuven","summary":"The Centre for Drug Design and Discovery raises 70.5 Million Euros for its fourth fund - KU Leuven","headline":"The Centre for Drug Design and Discovery raises 70.5 Million Euros for its fourth fund","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQ3dSdVVKUmxJOTNJMXFqZWdEdXgwaVRqYVIwSVBiSmk1NHI0bzJRSV9RQmxfZ3B2dnVXNWE0eEltVzhFTWpEWkczMFp6al9mR3RyQkVkRXBUbUp0Q1UtQ0hacjJGNzVCUWtUaHNUOXE3S1VtbXk0WDBNcENkT1daZ0FOa3lrUy1ZRnh5b0JTUnlIWUtBN3NwaW5SLS1idEZUY1hWaVdkTDhGd3g2VnRia3JOUzlfMEsx?oc=5","date":"2020-03-04","type":"pipeline","source":"The London School of Hygiene & Tropical Medicine","summary":"Average cost of developing a new drug could be up to $1.5 billion less than pharmaceutical industry claims - The London School of Hygiene & Tropical Medicine","headline":"Average cost of developing a new drug could be up to $1.5 billion less than pharmaceutical industry claims - The London ","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"phase_2":2,"marketed":4,"phase_1":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}